There are more than 300 clinical trials for people with type one diabetes (T1D), including diabetic complications—eye disease, kidney disease, nerve disease.  Many of these trials take place in the Northern Florida Chapter territory.  Here are a few of the clinical trial sites in our area and some of the studies they are currently recruiting for:

Virtual Study to learn about quality of life in youth with T1D Recruiting youth between the ages of 11 and 17 who have had T1D for at least 12 months. – NEW!! 

AdventHealth Translational Research Institute, Orlando  The scientists and clinicians at AdventHealth Research Institute are committed to extending and improving the quality of lives through education and world class, innovative translational research for various metabolic diseases including 1 diabetes. – NEW!!

• Gladiator study flyer – The GLADIATOR study is enrolling adolescents and adults ages 14 to 45 with type 1 diabetes. Patients must be currently or have been previously treated with insulin, with the first dose of insulin less than 180 days before enrollment. You can read more about the trial by visiting the study website. https://yourt1d.com/.
• Automated Insulin-Delivery Systems on Senior Adults Living With T1D – NEW!!
• AdventHealth Translational Research Institute’s Honey Study focuses on adolescents and children diagnosed with Type 1 diabetes within the previous three months. It will measure the levels of certain biomarkers in the blood that may indicate triggers of Type 1 diabetes to help find better ways of diagnosing the condition and tracking its progression.  – NEW!!

University of Florida Office of Clinical Research, Gainesville

• Inhale1 Flyer_Final 26July2021 – INHALE-1 is a research study that aims to evaluate the safety and effectiveness of an inhaled insulin product for use in children and teenagers with diabetes. – NEW!!
• Can a Probiotic Improve my T1D?  Study to determine if a new medically designed probiotic can improve beta cell function, gastrointestinal health, immune function, and c-peptide levels in recently diagnosed T1Ds between the ages of 8 and 45 years old. – NEW!!
• Child_Recruitment Flyer_Sept 22 2020
• Jaeb Center for Health Research, Tampa
• CamAPSFX flyer_20 Sept 2021_NOT STAMPED 9.20.2021 
• PEDAP Recruitment Flyer_STAMPED.docx – The Pediatric Artificial Pancreas (PEDAP) Trial: A Randomized Controlled Comparison of the Control-IQ Technology versus Standard of Care in Young Children in Type 1 Diabetes

USF Health Diabetes and Endocrinology Center, Tampa

• Click here for further information on all available studies at the USF  Health Diabetes and Endocrinology Center, including the following studies:
  • Prevent or delay progression of T1D in those at higher risk
  • Protection of beta cell function in people newly diagnosed with T1D (within 150 days).
  • Diabetes device studies

Breakthrough T1D T1D Clinical Trials Connection

Breakthrough T1D funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease.  Currently, there are more than 70 Breakthrough T1D-funded clinical trials, to both prevent and treat this disease and its complications. We hope that, ultimately, these trials will lead to a cure for T1D.

That’s where Breakthrough T1D comes in. Breakthrough T1D has an easy-to-use tool to find a clinical trial that might be right for you. The online Clinical Trials Connection asks users some simple questions about themselves before matching them with trials for which they are eligible. Clinical Trials Connection uses your city, distance you’re willing to travel and other characteristics to narrow down hundreds of trials to the ones in which you might be interested.

Click Here to try it out!